SCHEMBL106108

SCHEMBL106108

CCCNN[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652517 0.83
SCHEMBL2880168 0.81
SCHEMBL7168259 0.79 EPHX1 (0.44)
SCHEMBL7167271 0.79 EPHX1 (0.44)
SCHEMBL7168977 0.79 EPHX1 (0.44)
SCHEMBL1751592 0.75
SCHEMBL7849378 0.71
SCHEMBL17225476 0.71
SCHEMBL2498775 0.71
SCHEMBL11161162 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867525-A Dihydrocyclopentaisoquinoline derivatives UCB生物制药有限责任公司 2022-08-05 CN claimed
CN-111303070-A Thiazolinone heterocyclic compounds, process for preparation thereof and pharmaceutical composition comprising the same 中国科学技术大学 2020-06-19 CN claimed
US-6569449-B1 For treatment of eating disorders, narcotic dependence and alcoholism. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2003-05-27 US claimed
CN-114867525-A Dihydrocyclopentaisoquinoline derivatives UCB生物制药有限责任公司 2022-08-05 CN disclosed
CN-109111408-B Thiazolinone heterocyclic compound, preparation method thereof, medicinal composition and application 中国科学技术大学 2021-03-09 CN disclosed
US-10870661-B2 Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity SHIONOGI & CO., LTD. (JP) 2020-12-22 US disclosed
CN-111303070-A Thiazolinone heterocyclic compounds, process for preparation thereof and pharmaceutical composition comprising the same 中国科学技术大学 2020-06-19 CN disclosed
CN-107151250-B Pyrimidine seven-membered ring compound, preparation method thereof, medicinal composition and application thereof 安徽省新星药物开发有限责任公司 2020-03-27 CN disclosed
US-20200055873-A1 NITROGEN-CONTAINING TRICYCLIC DERIVATIVES HAVING HIV REPLICATION INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2020-02-20 US disclosed
US-20180162876-A1 NITROGEN-CONTAINING TRICYCLIC DERIVATIVES HAVING HIV REPLICATION INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2018-06-14 US disclosed
US-9975906-B2 Tricyclic heterocycle derivatives having HIV replication inhibitory effect SHIONOGI & CO., LTD. (JP) 2018-05-22 US disclosed
US-7262001-B2 Heat-developable photosensitive material and an image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-08-28 US disclosed
US-20070049620-A1 Cyclic tertiary amine compound SANKYO COMPANY, LIMITED (JP) 2007-03-01 US disclosed
EP-1632488-A1 CYCLIC TERTIARY AMINE COMPOUND Sankyo Company, Limited (JP) 2006-03-08 EP disclosed
US-20050170298-A1 Heat-developable photosensitive material and an image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2005-08-04 US disclosed
US-6569449-B1 For treatment of eating disorders, narcotic dependence and alcoholism. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2003-05-27 US disclosed
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed
US-4377591-A CARBAPENICILLIN ANTIBIOTICS SANKYO COMPANY, LIMITED (JP) 1983-03-22 US disclosed